article thumbnail

Thermo Fisher Scientific opens sterile drug facility in Singapore

Pharmaceutical Technology

It comes with quick vaccine fill-finish capabilities and offers end-to-end pharmaceutical development and manufacturing services. With this expansion we are strategically prepared, more than ever, to respond to our customers’ needs by supporting the accelerated delivery of critical vaccines and medicines to patients.”

article thumbnail

U.S. polio case tied to viruses detected in U.K., Israel, suggesting silent spread

STAT News

Genetic analysis of the virus responsible for the first case of polio in the United States in nearly a decade shows it is linked to vaccine-derived viruses recently detected in Jerusalem and London, the Global Polio Eradication Initiative announced on Friday.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Minimal SARS-CoV-2 diversity suggests a global vaccine is feasible

Scienmag

Genetic analysis of sequences from more than 27,000 individuals infected with the coronavirus that causes COVID-19 reveals that the virus has mutated minimally since December 2019, suggesting one vaccine would be sufficient to combat global infections.

article thumbnail

Opinion: Polio in New York: A call to action for U.S. pediatricians and public health to work together

STAT News

Third, genetic analysis indicated that the strain of polio is one that evolved from an oral polio vaccine — which uses a weakened live virus — and is identical to the strain that has caused community transmission in London and Israel , indicating this is problem in multiple countries that were previously considered polio-free.

article thumbnail

Top 10 Biotech Trends for 2025

XTalks

Biomanufacturing and Automation The production of vaccines, drugs and diagnostic reagents increasingly depends on good manufacturing practice (GMP) facilities for the manufacturing of critical reagents, a reliance that has intensified since the pandemic. The global NGS market is projected to grow from $13.0 billion in 2022 to $27.0